Google Translate Widget by Infofru

Author Site Reviewresults

ASCO Abstract

Personalized multimodality therapy with immune checkpoint inhibitors (ICI), chemotherapy (CT), and targeted treatment (TT) in advanced refractory cancer.

Category:
Developmental Immunotherapy and Tumor Immunobiology
Sub-category
Other IO-Related Topics
Meeting
2019 ASCO Annual Meeting

Download Abstract

Contact Us

Please let us know your name.
Please enter your last name
Please let us know your email address.
Please enter your phone number

Salem Oncology Center

6624 Fannin, Ste 1630, Houston, TX 77030 | Phone: 713-796-1221 | This email address is being protected from spambots. You need JavaScript enabled to view it.
Mon-Fri: 8:30AM - 6:30PM | Sat-Sun: 9:00AM-2:00PM